294863-22-2

Downstream Products

• 335022-98-5 1-[(2S,3R)-2-benzyloxy-5-(2-naphthyloxy)-3-pentyl]imidazole-4-carboxamide 
• 294862-80-9 1-[(2S,3R)-2-benzyloxy-5-(tert-butyldimethylsilyloxy)-3-pentyl]imidazole-4-carboxamide 
• 294863-25-5 1-[(2S,3R)-2-benzyloxy-5-methylsulfonyloxy-3-pentyl]imidazole-4-carboxamide 
• 294863-24-4 1-[(2S,3R)-2-benzyloxy-5-hydroxy-3-pentyl]imidazole-4-carboxamide 
• 700363-47-9 (3S,4S)-4-benzyloxy-1-(tert-butyldimethylsilyloxy)pentan-3-ol 
• 294862-91-2 (3S,4S)-4-benzyloxypentane-1,3-diol 

Relevant academic research and scientific papers

Enantioselective synthesis of putative lipiarmycin aglycon related to fidaxomicin/tiacumicin B

An enantioselective synthesis of a putative lipiarmycin aglycon was accomplished and features: 1) Brown's enantioselective alkoxyallylboration and allylation of aldehydes, 2) chain elongation by iterative Horner-Wadsworth-Emmons olefination, 3) Evans' aldol reaction and 4) an enediene ring-closing metathesis. A neighboring-group-assisted chemoselective reductive desilylation was uncovered in this study and was instrumental to the realization of the present synthesis.

Heterocyclic compound, composition and method for inhibiting adenosine deaminase

Heterocyclic compounds of the following formula: wherein B is ?[wherein R1is hydrogen or lower alkyl; R2is hydrogen or lower alkyl; and X is hydrogen or hydroxy protective group], lower alkanoyl or hydroxyimino(lower)alkyl A is lower